Invention Application
US20090209564A1 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
有权
胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
- Patent Title: Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
- Patent Title (中): 胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
-
Application No.: US12225056Application Date: 2007-03-19
-
Publication No.: US20090209564A1Publication Date: 2009-08-20
- Inventor: Ronald M. Kim , Emma R. Parmee , Qiang Tan , Ashley Rouse Lins , Jiang Chang , Cangming Yang
- Applicant: Ronald M. Kim , Emma R. Parmee , Qiang Tan , Ashley Rouse Lins , Jiang Chang , Cangming Yang
- Assignee: Merck & Co., Inc.
- Current Assignee: Merck & Co., Inc.
- International Application: PCT/US2007/006806 WO 20070319
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07C233/78 ; A61K31/192 ; A61K31/47 ; C07D215/06 ; C07D239/34 ; A61P3/10
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US07989472B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Public/Granted day:2011-08-02
Information query
